BASF’s Capital Discipline Faces a Defining Moment as Buyback Program Nears Expiry

With just weeks left before its €1.5 billion share repurchase programme wraps up at the end of June, BASF enters a stretch of heightened scrutiny. The chemicals giant has committed to returning at least €12 billion to shareholders between 2025 and 2028 — underpinned by €8 billion in dividends and a minimum €4 billion in buybacks — but the market is still waiting for a concrete roadmap for the remaining €2.5 billion of share purchases after the current tranche expires. That gap in clarity is putting the company’s financial strategy squarely in the spotlight.

The buyback that began in November 2025 has gathered steady momentum. As of June 1, BASF had acquired 950,000 of its own shares, bringing the cumulative total to 27,835,549. The repurchased stock is set to be cancelled, reducing the share count and providing an earnings-per-share tailwind. The programme forms the initial slab of the larger €4 billion buyback pledge, but the timetable for the next phase remains unspecified, leaving investors to guess whether the company will announce a fresh tranche immediately or pause after the current one ends.

That pause could prove uncomfortable if the operating environment fails to rally. BASF’s first-quarter figures reveal a business under persistent pressure: revenue slipped 3% year-on-year to €16.0 billion, while EBITDA before special items fell to €2.356 billion from €2.495 billion a year earlier. Management has maintained its full-year guidance of €6.2 billion to €7.0 billion in underlying EBITDA, a wide band that reflects considerable macro uncertainty. The German Chemical Industry Association (VCI) predicts flat output for the chemical-pharmaceutical sector in 2026 and a 1% contraction for pure chemicals, with revenue potentially dropping 3.5% if prices soften further. A weak US dollar, elevated energy costs and the ripple effects from the Middle East conflict are all weighing on the outlook.

Should investors sell immediately? Or is it worth buying BASF?

Against that backdrop, all eyes are on BASF’s costly bet on China. The new integrated Verbund site in Zhanjiang, opened in March 2026, came in at €8.7 billion — notably below its original budget and delivered on time. Yet chief executive Markus Kamieth has already tempered expectations for the petrochemical plant’s near-term profitability, citing industry-wide overcapacity and slower Chinese growth. While BASF continues to see solid demand from China’s customer industries and export channels, the pace of expansion is expected to moderate. The site remains a strategic linchpin for the corporate overhaul, but its contribution to earnings is still some way off.

Market opinion is sharply divided on whether the payout promise is sustainable. Analysts at Deutsche Bank rate the stock a “Buy” with a €60 target, arguing that the valuation is attractive and buyback demand provides a floor. Goldman Sachs is even more bullish at €65, citing higher EBITDA estimates and confidence in cost-cutting momentum. JP Morgan, however, has slapped an “Underweight” rating and a €40 price target, pointing to weak demand visibility and currency headwinds. That divergence captures the central tension: attractive capital returns versus a challenging operational reality.

The share price reflects the stand-off. BASF closed at €50.55 on Friday, up 12.99% year-to-date but 3.54% below its short-term moving average. It trades 7.96% above the long-term average of €46.82, and the relative strength index sits at a neutral 42.4. The near-term focus will be on the zone around €50 — a decisive break below that level could signal deeper weakness, with the next support at €49.97.

The immediate agenda is clear: BASF must flesh out the remaining buyback timeline well before the half-year results land on July 30. Until then, the shares are caught between a generous payout pledge and an industrial cycle that is offering no favours.

Ad

BASF Stock: New Analysis - 7 June

Fresh BASF information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated BASF analysis...

en | DE000BASF111 | BASF’S | boerse | 69495937 |